SAN CLEMENTE, Calif.--(BUSINESS WIRE)--U.S. Patent & Trademark Office has granted a patent to Sensory NeuroStimulation Inc. for Relaxis, the first and only FDA-cleared, non-drug treatment for Restless Legs Syndrome (RLS).